Skip to main content

Advertisement

SpringerLink
Log in

Tumour response of osteosarcoma to neoadjuvant chemotherapy evaluated by magnetic resonance imaging as prognostic factor for outcome

  • Original Paper
  • Published:
International Orthopaedics Aims and scope Submit manuscript

Abstract

Purpose

This study evaluated the feasibility of computed magnetic resonance imaging (MRI) volumetry in conventional osteosarcomas. Secondly, we investigated whether computed volumetry provides new prognostic indicators for histological response of osteosarcomas after neoadjuvant chemotherapy.

Methods

In a retrospective cohort study, data from the Vienna Bone Tumour Registry was used. MR images from 14 patients (male:female = 1.8, mean age 19 years) were analysed prior to and after neoadjuvant chemotherapy according to current therapy regimens. Histological response to chemotherapy was graded according to the Salzer-Kuntschik classification. Computed volumetry was performed for the intraosseous part, as well as the soft-tissue component and the tumour as a whole.

Results

In a setting of appropriate radiological equipment, the method has been considered to be well implementable into clinical routine. The mean tumour volume prior to chemotherapy was 321 (±351) ml. In good responders (n = 6), overall tumour volume decreased by 47 % (p = 0.345), whereas poor responders (n = 8) showed a 19 % decrease (p = 0.128). Neoadjuvant multidrug therapy remarkably changed the tumour composition. This is seen in a decrease of the mean ratio of soft-tissue to intraosseous tumour volume from 8.67 in poor responders and 1.15 in good responders to 1.26 and 0.45 (p = 0.065), respectively. Interestingly, the bony compartment of good responders showed a volume increase during neoadjuvant chemotherapy (p = 0.073). However, we did not find prognostic markers for histological tumour response to pre-operative chemotherapy.

Conclusions

Separated volumetry of tumour segments revealed interesting insights into therapy-induced growth patterns. If verified in a larger study population, these results should be taken into account when planning ablative surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Fletcher C, Unni K, Mertens F (2002) World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone. IARC Press, Lyon, pp 264–284

    Google Scholar 

  2. Carrle D, Bielack SS (2006) Current strategies of chemotherapy in osteosarcoma. Int Orthop 30:445–451. doi:10.1007/s00264-006-0192-x

    Article  PubMed Central  PubMed  Google Scholar 

  3. Jaffe N (2010) Osteosarcoma: review of the past, impact on the future. The american experience. Cancer Treat Res 152:239–262. doi:10.1007/978-1-4419-0284-9_12

    Article  Google Scholar 

  4. Li X, Moretti VM, Ashana AO, Lackman RD (2012) Impact of close surgical margin on local recurrence and survival in osteosarcoma. Int Orthop 36:131–137. doi:10.1007/s00264-011-1230-x

    Article  PubMed Central  PubMed  Google Scholar 

  5. Hayashi K, Tsuchiya H, Yamamoto N et al (2008) Functional outcome in patients with osteosarcoma around the knee joint treated by minimised surgery. Int Orthop 32:63–68. doi:10.1007/s00264-006-0289-2

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Marina N, Bielack S, Whelan J et al (2010) International collaboration is feasible in trials for rare conditions: the EURAMOS experience. Cancer Treat Res 152:339–353. doi:10.1007/978-1-4419-0284-9_18

    Article  Google Scholar 

  7. Funovics PT, Edelhauser G, Funovics MA et al (2011) Pre-operative serum C-reactive protein as independent prognostic factor for survival but not infection in patients with high-grade osteosarcoma. Int Orthop 35:1529–1536. doi:10.1007/s00264-011-1208-8

    Article  PubMed Central  PubMed  Google Scholar 

  8. Rastogi S, Kumar R, Sankineani SR et al (2012) Role of vascular endothelial growth factor as a tumour marker in osteosarcoma: a prospective study. Int Orthop 36:2315–2321. doi:10.1007/s00264-012-1663-x

    Article  PubMed Central  PubMed  Google Scholar 

  9. Davis AM, Wright JG, Williams JI et al (1996) Development of a measure of physical function for patients with bone and soft tissue sarcoma. Qual Life Res 5:508–516

    Article  CAS  PubMed  Google Scholar 

  10. Picci P, Sangiorgi L, Rougraff BT et al (1994) Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma. J Clin Oncol 12:2699–2705

    CAS  PubMed  Google Scholar 

  11. Salzer-Kuntschik M, Delling G, Beron GR (1983) Morphological grades of regression in osteosarcoma after polychemotherapy—study COSS 80. J Cancer 106:21–24

    Google Scholar 

  12. Bajpai J, Gamnagatti S, Kumar R et al (2011) Role of MRI in osteosarcoma for evaluation and prediction of chemotherapy response: correlation with histological necrosis. Pediatr Radiol 41:441–450. doi:10.1007/s00247-010-1876-3

    Article  PubMed  Google Scholar 

  13. Bacci G, Lari S (2001) Adjuvant and neoadjuvant chemotherapy in osteosarcoma. Chir Organi Mov 86:253–268

    CAS  PubMed  Google Scholar 

  14. Kong C, Hansen M (2009) Biomarkers in osteosarcoma. Expert Opin Med 3:13–23. doi:10.1517/17530050802608496.Biomarkers

    Article  CAS  Google Scholar 

  15. Bieling P, Rehan N, Winkler P et al (1996) Tumor size and prognosis in aggressively treated osteosarcoma. J Clin Oncol 14:848–858

    CAS  PubMed  Google Scholar 

  16. Kim MS, Lee S-Y, Cho WH et al (2008) Initial tumor size predicts histologic response and survival in localized osteosarcoma patients. J Surg Oncol 97:456–461. doi:10.1002/jso.20986

    Article  PubMed  Google Scholar 

  17. Holscher H, Bloem J, Van der Woude H et al (1995) Can MRI predict the histopathological response in patients with osteosarcoma after the first cycle of chemotherapy? Clin Radiol 50:384–390

    Article  CAS  PubMed  Google Scholar 

  18. Bielack S, Jürgens H, Jundt G et al (2010) Osteosarcoma: the COSS experience. Cancer Treat Res 152:289–308. doi:10.1007/978-1-4419-0284-9_15

    Article  Google Scholar 

  19. Denecke T, Hundsdörfer P, Misch D et al (2010) Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters. Eur J Nucl Med Mol Imaging 37:1842–1853. doi:10.1007/s00259-010-1484-3

    Article  PubMed  Google Scholar 

  20. Schima W, Amann G, Stiglbauer R et al (1994) Preoperative staging of osteosarcoma: efficacy of MR imaging in detecting joint involvement. AJR Am J Roentgenol 163:1171–1175

    Article  CAS  PubMed  Google Scholar 

  21. Hoffer FA, Nikanorov AY, Reddick WE et al (2000) Accuracy of MR imaging for detecting epiphyseal extension of osteosarcoma. Pediatr Radiol 30:289–298

    Article  CAS  PubMed  Google Scholar 

  22. Masrouha KZ, Musallam KM, Samra AB et al (2012) Correlation of non-mass-like abnormal MR signal intensity with pathological findings surrounding pediatric osteosarcoma and Ewing’s sarcoma. Skeletal Radiol 41:1453-1461. doi:10.1007/s00256-012-1383-8

    Article  PubMed  Google Scholar 

  23. James SLJ, Panicek DM, Davies AM (2008) Bone marrow oedema associated with benign and malignant bone tumours. Eur J Radiol 67:11–21. doi:10.1016/j.ejrad.2008.01.052

    Article  CAS  PubMed  Google Scholar 

  24. Yamamura S, Sato K, Sugiura H et al (1997) Prostaglandin levels of primary bone tumor tissues correlate with peritumoral edema demonstrated by magnetic resonance imaging. Cancer 79:255–261

    Article  CAS  PubMed  Google Scholar 

  25. Shinmura K, Ishida T, Goto T et al (2004) Expression of cyclooxygenase-2 in chondroblastoma: immunohistochemical analysis with special emphasis on local inflammatory reaction. Virchows Arch 444:28–35. doi:10.1007/s00428-003-0889-9

    Article  CAS  PubMed  Google Scholar 

  26. White LM, Wunder JS, Bell RS et al (2005) Histologic assessment of peritumoral edema in soft tissue sarcoma. Int J Radiat Oncol Biol Phys 61:1439–1445. doi:10.1016/j.ijrobp.2004.08.036

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Orthopaedic Surgery, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria

    Christoph J. Laux, Martin Dominkus, Reinhard Windhager & Philipp T. Funovics

  2. Department of Radiology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria

    Gundula Berzaczy, Michael Weber & Iris-Melanie Nöbauer-Huhmann

  3. Department of Clinical Pathology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria

    Susanna Lang

Authors
  1. Christoph J. Laux
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gundula Berzaczy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael Weber
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Susanna Lang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Martin Dominkus
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Reinhard Windhager
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Iris-Melanie Nöbauer-Huhmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Philipp T. Funovics
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Christoph J. Laux or Philipp T. Funovics.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Laux, C.J., Berzaczy, G., Weber, M. et al. Tumour response of osteosarcoma to neoadjuvant chemotherapy evaluated by magnetic resonance imaging as prognostic factor for outcome. International Orthopaedics (SICOT) 39, 97–104 (2015). https://doi.org/10.1007/s00264-014-2606-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00264-014-2606-5

Keywords

Search

Navigation